Cargando…
Drug Screening Identifies Niclosamide as an Inhibitor of Breast Cancer Stem-Like Cells
The primary cause of death from breast cancer is the progressive growth of tumors and resistance to conventional therapies. It is currently believed that recurrent cancer is repopulated according to a recently proposed cancer stem cell hypothesis. New therapeutic strategies that specifically target...
Autores principales: | Wang, Yu-Chi, Chao, Tai-Kuang, Chang, Cheng-Chang, Yo, Yi-Te, Yu, Mu-Hsien, Lai, Hung-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776833/ https://www.ncbi.nlm.nih.gov/pubmed/24058587 http://dx.doi.org/10.1371/journal.pone.0074538 |
Ejemplares similares
-
Ovarian cancer stem-like cells with induced translineage-differentiation capacity and are suppressed by alkaline phosphatase inhibitor
por: Liu, Kuei-Chun, et al.
Publicado: (2013) -
Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer
por: Lin, Chi-Kang, et al.
Publicado: (2016) -
Niclosamide Revitalizes Sorafenib through Insulin-like Growth Factor 1 Receptor (IGF-1R)/Stemness and Metabolic Changes in Hepatocellular Carcinoma
por: Peng, Syue-Wei, et al.
Publicado: (2023) -
Computational Screening Strategy for Drug Repurposing Identified Niclosamide as Inhibitor of Vascular Calcification
por: Tanaka, Takeshi, et al.
Publicado: (2022) -
Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission
por: Wang, Yu-Ming, et al.
Publicado: (2016)